Merck KGaA (MKKGY)
32.55
+0.19
(+0.59%)
USD |
OTCM |
Aug 25, 16:00
Merck EPS Diluted (Quarterly) : 0.2621 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.2621 |
| March 31, 2026 | 0.3547 |
| December 31, 2025 | 0.1708 |
| September 30, 2025 | 0.4849 |
| June 30, 2025 | 0.3399 |
| March 31, 2025 | 0.3558 |
| December 31, 2024 | 0.3273 |
| September 30, 2024 | 0.4088 |
| June 30, 2024 | 0.3006 |
| March 31, 2024 | 0.3465 |
| December 31, 2023 | 0.2899 |
| September 30, 2023 | 0.3698 |
| June 30, 2023 | 0.3525 |
| March 31, 2023 | 0.3929 |
| December 31, 2022 | 0.3072 |
| September 30, 2022 | 0.4274 |
| June 30, 2022 | 0.4245 |
| March 31, 2022 | 0.4541 |
| December 31, 2021 | 0.4217 |
| September 30, 2021 | 0.4126 |
| June 30, 2021 | 0.4132 |
| March 31, 2021 | 0.4139 |
| December 31, 2020 | 0.2391 |
| September 30, 2020 | 0.4328 |
| June 30, 2020 | 0.1469 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.2311 |
| December 31, 2019 | 0.162 |
| September 30, 2019 | 0.1754 |
| June 30, 2019 | 0.2435 |
| March 31, 2019 | 0.0987 |
| December 31, 2018 | 0.1059 |
| September 30, 2018 | 0.1819 |
| June 30, 2018 | 0.1358 |
| March 31, 2018 | 0.1917 |
| December 31, 2017 | 0.5487 |
| September 30, 2017 | 0.3503 |
| June 30, 2017 | 0.2169 |
| March 31, 2017 | 0.257 |
| December 31, 2016 | 0.1336 |
| September 30, 2016 | 0.2349 |
| June 30, 2016 | 0.1617 |
| March 31, 2016 | 0.2999 |
| December 31, 2015 | 0.0635 |
| September 30, 2015 | 0.1867 |
| June 30, 2015 | 0.1754 |
| March 31, 2015 | 0.144 |
| December 31, 2014 | 0.1599 |
| September 30, 2014 | 0.1511 |
| June 30, 2014 | 0.1923 |
| March 31, 2014 | 0.1027 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| STRATEC SE | 0.3981 |
| Sartorius AG | 0.2219 |
| Petros Pharmaceuticals, Inc. | -0.3038 |
| Danaher Corp. | 1.230 |
| Illumina, Inc. | 1.353 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 574.38M |
| Revenue (Quarterly) | 6.318B |
| Total Expenses (Quarterly) | 5.748B |
| Enterprise Value | 33.00B |
| Gross Profit Margin (Quarterly) | 58.26% |
| Profit Margin (Quarterly) | 9.09% |
| Earnings Yield | 3.91% |
| Operating Earnings Yield | 6.86% |
| Normalized Earnings Yield | 4.609 |